Results

Total Results: 722 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

441. VU EPC DBD Protocol_AHRQ comments_revised_clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_research-protocol.pdf
     January 30, 2014 - We added inactive treatments and usual care (e.g., wait list controls, placebo, and treatment as usual … [sh] OR therapeutics[mh] OR teaching[mh] OR psychotherapy[mh] OR treatment outcome[mh] 6618402 #3 … [sh] OR therapeutics[mh] OR teaching[mh] OR psychotherapy[mh] OR treatment outcome[mh] OR “Adolescent … [sh] OR therapeutics[mh] OR teaching[mh] OR psychotherapy[mh] OR treatment outcome[mh] OR “Adolescent … "[Mesh:NoExp] OR treatment[tiab] OR therapy[tiab] OR training[tiab] OR "Treatment Outcome"[Mesh] OR

442. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
     January 01, 2021 - Physiotherapy (n=45); core stability-based physiotherapy treatment; two sessions of therapy per week … 55% Arthritis in other joints: 24% vs. 21% vs. 15% Cardiovascular disease: 13% vs. 6% vs. 11% Type 2 diabetes … during the last 12 months; (4) previous experience in meditation or other mind-body therapies; (5) presence … therapy referral. … than 12 weeks and with no underlying inflammatory or neoplastic disease Exclusion: Patients with diabetes

443. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
     January 01, 2021 - Physiotherapy (n=45); core stability-based physiotherapy treatment; two sessions of therapy per week … 55% Arthritis in other joints: 24% vs. 21% vs. 15% Cardiovascular disease: 13% vs. 6% vs. 11% Type 2 diabetes … during the last 12 months; (4) previous experience in meditation or other mind-body therapies; (5) presence … therapy referral. … than 12 weeks and with no underlying inflammatory or neoplastic disease Exclusion: Patients with diabetes

444. The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/risk-cardiovascular-disease.pdf
     January 01, 2023 - States,4 with a projected future increase in cardiovascular disease risk factors which include type II diabetes … diagnosed with the endpoint outcomes of interest) • Participants who intend to reduce weight or receive treatments … Lancet Diabetes Endocrinol. 2017 Oct;5(10):774-87. doi: 10.1016/S2213-8587(17)30283-8. … high-carbohydrate versus a high--cis- monounsaturated fat diet on blood pressure in patients with type 2 diabetes … Diabetes Care. 2005 Nov;28(11):2607-12. doi: 10.2337/diacare.28.11.2607. PMID: 16249527. 27.

445. Gout Dx protocol_140715-draft (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol-2014.pdf
     January 01, 2014 - hyperuricemia, including obesity, hypertension, hypertriglyceridemia, hypercholesterolemia, type 2 diabetes … However, the role of diet in the etiology and treatment of gout is a topic of considerable research … Patients with comorbidities including hypertension, type 2 diabetes, kidney disease (renal insufficiency … relevant long-term outcomes (such as development of tophi, repeated flares that respond to urate lowering therapies … Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics

446. Abnormal-Uterine-Bleeding Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/abnormal-uterine-bleeding_research-protocol.pdf
     November 21, 2011 - options for AUB. 18 Nonsurgical treatment options–Pharmacologic therapies used for treatment of … , placebo, or no therapy for the treatment of heavy menstrual bleeding. 27 In a clinical review for … The Key Questions address nonsurgical therapeutic approaches (i.e., medical management, behavioral … current and prior contraception, perimenopausal status, fibroid status and comorbidities including diabetes … Tranexamic acid therapy for heavy menstrual bleeding.

447. Research White Paper - Assessing the Predictive Validity of Strength of Evidence Grades: A Meta-Epidemiological Study (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper.pdf
     September 01, 2015 - reports that: (1) include an outcome with more than eight randomized controlled trials (RCTs) on therapeutic … procedures and incontinence 693 RR: 0.97 (0.78 to 1.2) Wilhelmus et al., 201044 Antiviral therapies … Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone … Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes … Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis

448. Lumbar-Fusion-Draft-Report-Appendix-D (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-draft-report-appendix-d.xlsx
     January 01, 2019 - sites) Eligible Sample Randomized/Enrolled Sample Analyzed Sample Intervention Comparator Concomitant Therapies … Primary diagnosis is degenerative spondylolithesis NR NR NR 1 NR NR 64.3 vs. 65.3 18/28 vs. 8/13 NR NR Diabetes … 64.0 to 74.0) Female: 127/256 vs. 36/72 Median (IQR): 26.7 (24.1 to 30.3) vs. 27.4 (24.1 to 28.9) NR Diabetes … Enrolled Sample Analyzed Sample Intervention Comparator Repeat procedure/injections Crossover Concomitant Therapies … groups, 6 LFJs from L3/L4–L5/S1 were involved in therapy."

449. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
     May 19, 2010 - Atypical antipsychotics are approved by the United States Food and Drug Administration (FDA) for treatment … Neutropenia Agranulocytosis Leukopenia Metabolic syndrome Weight gain/loss Hyperglycemia/diabetes … efficacy and comparative effectiveness (versus placebo, versus other atypicals, or versus conventional therapy … contamination); the overall proportion of subjects lost to follow-up and important differences between treatments … is to summarize the evidence for efficacy and effectiveness (versus placebo or versus conventional therapy

450. Liver-Cancer-Therapy Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
     May 01, 2013 - overload syndromes, nonalcoholic fatty Effective Health Care Program 2 liver disease, obesity, diabetes … Three RCTs compared the ablative treatments RFA and PEI/PAI. … for the treatment of HCC is insufficient to support the effectiveness of one local hepatic therapy … The setting in which treatment occurs is a potential factor in the outcomes of local hepatic therapy … However, these clinical events may mark changes in therapies and treatment that may be important to

451. Allergy-Seasonal Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
     July 01, 2013 - headaches, and irritability.4,22 Decongestants are used with caution, if at all, in patients with diabetes … Drugs used for the treatment of SAR have wide therapeutic windows—that is, across the range of doses … Study designs that can more efficiently assess the effects of additive therapies are lacking. … Antihistamine therapy in allergic rhinitis. … Montelukast as an adjuvant to mainstay therapies in patients with seasonal allergic rhinitis.

452. Fecal-Incontinence Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_research-protocol.pdf
     November 30, 2014 - age, female sex, chronic diarrhea, nerve damage (such as from injury, multiple sclerosis, or chronic diabetes … Conversely, the ultimate treatments may be aimed at mitigating earlier FI treatment failures. … Key Questions 1 and 2: • Nonsurgical o Functional enhancement therapies (muscle training/biofeedback … • Combined treatments: any combination Comparators • All other treatment options, alone … and implementation (treatment fidelity) for nonpharmacologic treatments.

453. Management of Uterine Fibroids - Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
     December 01, 2017 - Four studies evaluated therapies in postmenopausal women. … Among medical therapies, GnRH agonists, mifepristone, and ulipristal reduced fibroid size and improved … trajectories in which all initial treatments can be followed by all possible combinations of next treatments … uterine fibroids, growth patterns, and influences on growth (e.g., concurrent medical conditions like diabetes … No data is available to indicate whether use of therapeutics short of surgery might forestall or prevent

454. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/case-management_research-protocol.pdf
     June 06, 2011 - Context: Patients with complex health care needs because of multiple chronic conditions, multiple treatments … individual chronic diseases, including a review that found improved glycemic control among patients with diabetes … these investigators reported that case management may improve patient outcomes for heart failure and diabetes … Process measure outcomes (include but are not limited to): adherence to therapy; missed appointments … The effectiveness of disease and case management for people with diabetes: a systematic review.

455. Knowledge Brief #1 Public Deliberation on Health Topics (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/deliberative-methods_research.pdf
     February 01, 2013 - The object is to help consumers, health care providers, and others make informed choices among treatment … example: • Approaches to childhood obesity • Coverage for the uninsured • Cost-effectiveness of treatments … Health care reform • Pandemic planning • Personal health responsibility • Setting priorities for diabetes

456. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
     January 01, 2011 - iron therapy is preferred over oral therapy because it decreases ESA dosages and significantly increases … What targets of iron therapy should be achieved? … is usually determined by their indirect effects on outcomes, that is, through their influence on therapeutic … regimen (i.e., repletion or continuous treatment)  Interactions between treatments (i.e., patients … Bethesda, MD, National Institute of Diabetes and Digestive and Kidney Diseases; 2010.

457. Methods Research Report: Creating Efficiencies in the Extraction of Data From Randomized Trials (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-creating-efficiencies-extraction-data.pdf
     August 01, 2021 - (s), name of control treatment(s), dose (or number of sessions), frequency of treatment, route of treatment … , or educational 12 (16.0) Rehabilitation or psychosocial 12 (16.0) Device 11 (14.7) Alternative therapeutic … A randomized controlled comparison of emotional freedom technique and cognitive-behavioral therapy … Cognitive behavioural therapy stabilises glycaemic control in adolescents with type 1 diabetes-Outcomes … Pediatr Diabetes. 2018;19(1):106-113. doi: 10.1111/pedi.12519.

458. Medical-Evidence-Communication Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-evidence-communication_research-protocol.pdf
     July 31, 2012 - creates multiple challenges, including difficulties: (1) determining whether preventive services and treatments … benefits, and treatment harms. … National Institutes of Health (e.g., National Heart, Lung and Blood Institute; National Institute of Diabetes … “A lack of activity increases risk for diabetes.” … We will also consider studies that compare ways to explain net benefit (of prevention or therapeutic

459. Newly Medicare-Eligible Elders: Data Points #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-utilization-seniors_research.pdf
     June 01, 2012 - chronic conditions: cancer, Alzheimer’s, chronic obstructive pulmonary disease (COPD), depression, diabetes … † 3.6 3.4 2.9 2.8 Alzheimer’s 3.5 1.0 1.4 0.3 COPD 12.0 9.4 6.2 2.5 Depression 12.4 9.3 6.9 4.1 Diabetes … of full duals have at least one of our target conditions of cancer, Alzheimer’s, COPD, depression, diabetes … Methodological issues in the use of administrative claims data to study surveillance after cancer treatment … Chronic Obstructive Pulmonary Disease 11,266 2,253 4,080 57,189 Depression 11,632 2,246 4,554 95,030 Diabetes

460. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … unmet need for new therapeutic options for patients with IBS. … options, alternative therapies are needed. … Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); 2013 Sep … FDA approves two therapies to treat IBS-D. [internet]. Silver Spring (MD): U.S.